These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28135563)

  • 21. Mast cells as targets of pimecrolimus.
    Ma Z; Jiao Z
    Curr Pharm Des; 2011 Nov; 17(34):3823-9. PubMed ID: 22114844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic mastocytosis.
    Robyn J; Metcalfe DD
    Adv Immunol; 2006; 89():169-243. PubMed ID: 16682275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?
    Georgin-Lavialle S; Le Saché-de Peufeilhoux L; Martin L; Soucie E; Bruneau J; Barete S; Dubreuil P; Bodemer C; Hermine O; Lhermitte L
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):967-71. PubMed ID: 23763569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonality and molecular pathogenesis of mastocytosis.
    Akin C
    Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular alterations underlying eosinophilic and mast cell malignancies.
    Sadrzadeh H; Abdel-Wahab O; Fathi AT
    Discov Med; 2011 Dec; 12(67):481-93. PubMed ID: 22204765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The mast cell and its pathology. 2: Histopathology of mastocytosis].
    Lortholary O; Audouin J; Le Tourneau A; Diebold J
    Ann Pathol; 1991; 11(2):92-100. PubMed ID: 2053996
    [No Abstract]   [Full Text] [Related]  

  • 30. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.
    Gotlib J; Akin C
    Semin Hematol; 2012 Apr; 49(2):128-37. PubMed ID: 22449623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.
    Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M
    Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
    Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
    J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The mast cell and its pathology (1). Nosology and physiopathology of mast cell hyperplasia and proliferation].
    Lortholary O; Audouin J; Le Tourneau A; Diebold J
    Ann Pathol; 1991; 11(1):18-24. PubMed ID: 2036130
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro functional reactivities of cutaneous mast cells from patients with mastocytosis.
    Tharp MD; Chaker B; Glass MJ; Burton R; Seelig LL
    J Invest Dermatol; 1987 Sep; 89(3):264-8. PubMed ID: 3624898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell quantitation by image analysis in adult mastocytosis and inflammatory skin disorders.
    Wilkinson B; Jones A; Kossard S
    J Cutan Pathol; 1992 Oct; 19(5):366-70. PubMed ID: 1282134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mastocytosis.
    Metcalfe DD
    Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
    Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
    Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIT and mastocytosis.
    Lim KH; Pardanani A; Tefferi A
    Acta Haematol; 2008; 119(4):194-8. PubMed ID: 18566536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
    Valent P; Ghannadan M; Akin C; Krauth MT; Selzer E; Mayerhofer M; Sperr WR; Arock M; Samorapoompichit P; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2004 Aug; 34 Suppl 2():41-52. PubMed ID: 15291805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.